By Matt Grossman

 

Roche Holding AG on Friday said it has received an emergency-use authorization from the U.S. Food and Drug Administration for a test that can distinguish between Covid-19 and the flu.

The test is for Roche's cobas 6800/8800 system, which can process between 384 and 1,056 tests in an eight-hour period depending on the model used.

Roche said the test will help health-care providers determine which patients are sick with the flu and which are sick with Covid-19--a determination that will grow in importance as flu season approaches.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

September 04, 2020 07:11 ET (11:11 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Roche (QX) Charts.